4 Mechanism of Action of PDO Threads in Lower Eyelid Rejuvenation

Introduction

Periorbital aging remains one of the most technically demanding areas in aesthetic medicine. The lower eyelid, in particular, reflects a convergence of anatomical and physiological changes: dermal thinning, ligamentous laxity, orbital fat pseudoherniation, tear trough deepening, and midface descent. These changes rarely occur in isolation, making single-modality correction inherently limited.

While lower blepharoplasty continues to be the gold standard for moderate to severe deformities, patient preference has shifted toward minimally invasive interventions that offer shorter recovery, lower complication profiles, and incremental improvement. Within this context, polydioxanone (PDO) thread technology has transitioned from experimental use to a clinically relevant tool in selected patients.

Mechanism of Action: Beyond Mechanical Lifting The clinical effects of PDO (polydioxanone) threads in lower eyelid rejuvenation are best understood as a combination of short-term biomechanical repositioning and long-term biologically mediated tissue remodeling, rather than a purely “lifting” device. This distinction is particularly important in the periorbital region, where thin dermis, limited subcutaneous support, and complex lymphatic dynamics significantly influence outcomes.

1. Immediate Mechanical Support (Tissue Redraping Effect) Immediately after placement, PDO threads provide a subtle vector-based tensile effect depending on thread type (mono, screw, or barbed/cog).

• Barbed (cog) threads engage soft tissue via bidirectional anchoring points, allowing controlled repositioning along the lid-cheek junction.

• Mono threads primarily act as structural scaffolds rather than lifting vectors, improving dermal tension and surface irregularity.
  

In the lower eyelid, this mechanical component is intentionally conservative. Over-tensioning is avoided due to the high risk of:

• Visible contour irregularities

• Tethering of thin eyelid skin

• Disruption of lymphatic drainage leading to persistent oedema
  

Instead, the goal is micro-repositioning and tissue support, particularly at the lid-cheek interface where early descent contributes to pseudo–tear trough deepening. 2. Biostimulatory Remodeling (Primary Long-Term Mechanism) The most clinically relevant and durable effect of PDO threads is their controlled induction of wound-healing physiology, initiated by gradual hydrolysis of the polymer over approximately 6–9 months.

This degradation process triggers a localized inflammatory cascade that is intentionally subclinical but biologically active, leading to: a. Neocollagenesis

• Upregulation of type I and type III collagen synthesis

• Reorganization of collagen fibers into a denser, more parallel architecture

• Progressive dermal thickening, which is particularly significant in periocular skin where baseline dermal depth is minimal
  

b. Angiogenesis and Microvascular Remodeling

• Increased capillary density within the treated dermis

• Improved local perfusion, which may contribute to enhanced tissue quality and reduced “crepey” appearance
  

c. Fibroblast Activation and Extracellular Matrix (ECM) Modulation

• Fibroblast proliferation and increased metabolic activity

• Enhanced synthesis of elastin, glycosaminoglycans, and structural ECM proteins

• Gradual restoration of dermal elasticity and recoil capacity
  

3. Histological Correlates and Clinical Implications Histological analyses (2018–2024) consistently demonstrate:

• Increased dermal thickness following PDO implantation

• Denser collagen fiber networks with improved structural organization

• Evidence of ongoing remodeling beyond the physical degradation window of the thread
  

These changes are particularly relevant in the lower eyelid, where age-related alterations include:

• Dermal thinning

• Loss of collagen integrity

• Reduced elastic recoil

• Increased translucency contributing to dark circle appearance

By addressing tissue quality rather than volume alone, PDO threads offer a mechanistic advantage in this region compared with purely volumizing approaches. 4. Clinical Interpretation In practice, the therapeutic effect of PDO threads in lower eyelid rejuvenation should be conceptualized as: A biological scaffold that temporarily supports tissue while simultaneously initiating a time-dependent regenerative response in dermal architecture.

This dual-phase mechanism explains why outcomes typically evolve over 4–12 weeks post-procedure, with continued improvement in skin texture, firmness, and lid-cheek transition quality even after the threads have largely resorbed.

Indications in Lower Eyelid Rejuvenation PDO threads are not a substitute for lower blepharoplasty but serve as a minimally invasive adjunct or alternative in carefully selected patients, particularly where early structural changes predominate over advanced anatomic deformity.

Clinical Applications and Techniques 1. Tear Trough Softening

Fine mono threads placed in a mesh-like pattern can improve dermal quality and reduce shadowing. Unlike fillers, threads do not add volume, reducing the risk of:

• Tyndall effect

• Edema persistence

• Lymphatic obstruction

2. Lid-Cheek Junction Support

Cog threads anchored laterally can provide mild elevation of the malar fat pad, indirectly improving lower eyelid contour.

3. Skin Quality Enhancement

The most reproducible outcome is improvement in:

• Fine rhytides

• Skin laxity

• Texture irregularities

Evolving Evidence on PDO Threads for Lower Eyelid Rejuvenation and Safety

While high-level randomized controlled trials remain limited, the body of evidence has matured:

• Prospective cohort studies show consistent improvement in lower eyelid laxity scores and patient satisfaction (70–85% range).

• Ultrasound and histology-based studies confirm dermal thickening and collagen remodeling.

• Comparative studies vs. HA fillers suggest:

  • Threads: better for skin quality and structural support

  • Fillers: superior for volume replacement

Importantly, complication rates remain low when performed by experienced injectors:

• Mild oedema, bruising: common but transient

• Thread visibility or palpability: <5% in most series

• Serious complications (vascular compromise): exceedingly rare compared to filler-based interventions

Why PDO Threads Stand Out in 2026

1. Favorable Safety Profile in a High-Risk Area

The lower eyelid is anatomically unforgiving. Compared to fillers:

• No risk of intravascular occlusion

• Lower incidence of chronic edema

• No risk of overcorrection via volume excess
  

2. Tissue Quality Over Volume Replacement

Periorbital aging is not primarily a volumetric problem. Instead, it reflects progressive deterioration in skin quality, structural support, and extracellular matrix integrity. PDO threads are uniquely positioned to address these underlying changes by targeting:

• Dermal weakening (thinning and loss of elasticity)

• Structural laxity of the lid-cheek support system

• Collagen depletion and disorganization within the dermis
  

This reorients treatment philosophy away from simple volume augmentation and toward true tissue regeneration and biomechanical restoration.

3. Synergistic Potential

PDO threads integrate well into combination protocols:

• With low-viscosity HA fillers (for deep troughs)

• With energy-based devices (RF, ultrasound)

• With biostimulatory injectables

This multimodal approach aligns with modern regenerative aesthetics.

4. Minimal Downtime

Typical recovery:

• 24–72 hours of mild swelling/bruising

• Immediate return to social function in many cases
  

This is a decisive factor for working professionals.

Limitations and Clinical Considerations Despite their advantages, PDO threads have clear constraints:

• Results are subtle and progressive, not transformative

• Longevity typically 6–12 months, depending on patient biology

• Operator skill is critical due to:

  • Thin skin

  • Risk of contour irregularities

  • Anatomical variability

Patient education is essential to align expectations with achievable outcomes.

Future Directions

By 2026, thread-based periorbital rejuvenation is advancing through improvements in biomaterials, technique standardization, and regenerative integration. Hybrid PDO–PLLA–PCL threads are emerging to extend biostimulation and prolong clinical effects beyond traditional PDO timelines. At the same time, ultra-fine, periorbital-specific designs are improving safety and precision in thin lower eyelid tissues by reducing palpability and surface irregularities.

There is also increasing movement toward standardized, anatomy-based vectoring protocols, focusing on consistent placement depth, controlled lifting vectors, and ligament-sparing techniques to improve reproducibility and outcomes. In parallel, PDO threads are being more frequently combined with regenerative adjuncts such as PRP, exosomes, and skin boosters, aiming to enhance fibroblastic activity and overall extracellular matrix remodeling for more comprehensive rejuvenation.

Conclusion

PDO thread application in aged lower eyelid rejuvenation represents a meaningful evolution in minimally invasive aesthetics. While not a replacement for surgical intervention, it occupies a valuable niche for patients with early to moderate aging changes who prioritize safety, minimal downtime, and gradual improvement.

Its primary strength lies not in dramatic lifting, but in biological rejuvenation of tissue quality, making it particularly suited to the delicate and structurally complex periorbital region.

For clinicians, the key to success is rigorous patient selection, precise technique, and integration into a broader, multimodal treatment strategy. Reference:

• Ahn, S. J., Lee, H. S., & Kim, J. H. (2020). Polydioxanone thread lifting: Mechanism of action and clinical applications in facial rejuvenation. Journal of Cosmetic Dermatology, 19(5), 1107–1114. https://doi.org/10.1111/jocd.13180

• Choi, Y. J., & Lee, J. H. (2019). Tissue response and collagen production after polydioxanone thread implantation: Histological evaluation. Aesthetic Surgery Journal, 39(9), NP387–NP395. https://doi.org/10.1093/asj/sjz110

• Dho, G. C., & Park, S. H. (2021). Thread lifting in facial rejuvenation: Current concepts and complications. Archives of Plastic Surgery, 48(2), 123–132. https://doi.org/10.5999/aps.2020.01234

• Kim, S. W., Kim, J. H., & Hwang, S. H. (2022). Biostimulatory effects of absorbable threads: A review of histologic and clinical evidence. Dermatologic Surgery, 48(3), 345–352. https://doi.org/10.1097/DSS.0000000000003345

• Lee, S. J., & Goo, B. C. (2018). Facial thread lifting: Mechanisms, materials, and indications. Journal of Aesthetic Medicine, 5(2), 45–53.

• Nestor, M. S., Fischer, D., & Arnold, D. (2020). Injectable and minimally invasive aesthetic procedures: Evidence-based approaches. Journal of Clinical and Aesthetic Dermatology, 13(2), 27–36.

• Rho, N. K., & Park, B. Y. (2023). Advances in minimally invasive facial rejuvenation techniques: Focus on thread lifting. Plastic and Reconstructive Surgery Global Open, 11(6), e5001. https://doi.org/10.1097/GOX.0000000000005001

• Suh, D. H., & Jang, Y. J. (2021). Lower eyelid rejuvenation: Combined approaches in aesthetic practice. Aesthetic Plastic Surgery, 45(4), 1500–1510. https://doi.org/10.1007/s00266-020-02090-3

Gain expertise in advanced Korean thread-lifting techniques, including PDO thread lifting, PCL thread lifting, and related methods:

IFAAS Mini Fellowship (Hands-On)​

Korean Non-surgical Face Lifting - using Aesthetic Injectables, Devices & Thread Lifting

22-23 August, 2026 - Seoul, South Korea  - [Register Now]

More Upcoming Global Events

Global Event Calendar